Free Trial

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Down - Should You Sell?

Telix Pharmaceuticals Limited American Depositary Shares logo with Medical background
Remove Ads

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Get Free Report)'s share price gapped down prior to trading on Wednesday . The stock had previously closed at $16.71, but opened at $16.09. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $16.09, with a volume of 4,499 shares trading hands.

Wall Street Analysts Forecast Growth

TLX has been the topic of a number of research reports. UBS Group increased their target price on shares of Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the stock a "buy" rating in a report on Monday, January 27th. William Blair reissued an "outperform" rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research note on Wednesday, March 12th.

Read Our Latest Analysis on Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals Limited American Depositary Shares Trading Up 1.8 %

The business's 50 day simple moving average is $17.79.

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

(Get Free Report)

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.

See Also

Should You Invest $1,000 in Telix Pharmaceuticals Limited American Depositary Shares Right Now?

Before you consider Telix Pharmaceuticals Limited American Depositary Shares, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Telix Pharmaceuticals Limited American Depositary Shares wasn't on the list.

While Telix Pharmaceuticals Limited American Depositary Shares currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

5 International Stocks to Escape U.S. Market Volatility

5 International Stocks to Escape U.S. Market Volatility

MarketBeat’s Chris Markoch shares 5 international stock picks that could offer protection—and potential opportunity—amid the current market uncertainty.

Related Videos

3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
3 AI Stocks to Watch After NVIDIA’s Dip

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads